Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 701–800 of 1,001
Chronic sodium azide treatment impairs learning of the Morris water maze task
Bennett, M. C., & Rose, G. M. (1992) · Behavioral and Neural Biology · doi:10.1016/0163-1047(92)90967-9 · Cited by 44
Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease
Burke, W. J., Galvin, N. J., Chung, H. D., Stoff, S. A., Gillespie, K. N., Cataldo, A. M., & Nixon, R. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91177-0 · Cited by 43
Meana, J. J., Barturen, F., Garro, M. A., García‐Sevilla, J. A., Fontán, A., & Zarranz, J. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10067.x · Cited by 43
The Role of Cholinesterase Inhibitors in Alzheimerʼs Disease
Lamy, P. P. (1994) · CNS Drugs · doi:10.2165/00023210-199401020-00006 · Cited by 45
Mieling, M., Meier, H., & Bunzeck, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105393 · Cited by 43
Bhagat, K., Singh, J. V., Sharma, A., Kaur, A., Kumar, N., Gulati, H. K., Singh, A., Singh, H., & Bedi, P. M. S. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131085 · Cited by 44
Regional atrophy of the corpus callosum in dementia
Hallam, B. J., Brown, W. S., Ross, C., Buckwalter, J. G., Bigler, E. D., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., & Breitner, J. C. S. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080533 · Cited by 42
Vascular damage: A persisting pathology common to Alzheimer’s disease and traumatic brain injury
Franzblau, M., Gonzales-Portillo, C., Gonzales-Portillo, G. S., Diamandis, T., Borlongan, M. C., Tajiri, N., & Borlongan, C. V. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.012 · Cited by 45
Côté, P., & Parent, A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91314-5 · Cited by 44
Acetylcholinesterase‐immunoreactive axonal network in monkey visual cortex
Hedreen, J. C., Uhl, G. R., Bacon, S. J., Fambrough, D. M., & Price, D. L. (1984) · Journal of Comparative Neurology · doi:10.1002/cne.902260208 · Cited by 43
Self-citationBiochemistry and Pathophysiology of the Molecular Forms of Cholinesterases
Rakonczay, Z., & Brimijoin, S. (1988) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4899-1681-5_10 · Cited by 42
A 10-year perspective on donepezil
Cheewakriengkrai, L., & Gauthier, S. G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.760543 · Cited by 42
Current Therapeutic Targets for Alzheimer's Disease
Chaudhary, A., Maurya, P. K., Yadav, B. S., Singh, S., & Mani, A. (2018) · Journal of Biomedicine · doi:10.7150/jbm.26783 · Cited by 37
Mitić, M., & Pašti, T. D. L. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1931681 · Cited by 42
Manukhina, E. B., Goryacheva, A. V., Barskov, I. V., Викторов, И. В., Guseva, A. A., Pshennikova, M. G., Khomenko, I. P., Mashina, S. Y., Pokidyshev, D. A., & Malyshev, I. Y. (2010) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-010-9320-6 · Cited by 41
Darvesh, S., Pottie, I. R., Darvesh, K. V., McDonald, R. S., Walsh, R., Conrad, S., Penwell, A., Mataija, D., & Martin, E. V. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.066 · Cited by 41
Choi, J. H. K., Kaur, G., Mazzella, M. J., Morales-Corraliza, J., Levy, E., & Mathews, P. M. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122143 · Cited by 37
Oyanagi, K., Takahashi, H., Wakabayashi, K., & Ikuta, F. (1989) · Brain Research · doi:10.1016/0006-8993(89)91384-x · Cited by 43
The cholinergic deficit in Alzheimer's disease: impact on cognition, behaviour and function
Mega, M. S. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001942 · Cited by 50
Kása, P., Pákáski, M., Joó, F., & Lajtha, Á. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03478.x · Cited by 41
Kwo-On-Yuen, P. F., Mandel, R. J., Chen, A. D., & Thal, L. J. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90126-d · Cited by 41
Zhang, Z.-J., Berbos, T. G., Wrenn, C. C., & Wiley, R. G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12282-6 · Cited by 41
Bartus, R. T., Flicker, C., Dean, R. L., Fisher, S. K., Pontecorvo, M. J., & Figueiredo, J. C. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)64315-0 · Cited by 41
Mustazza, C., Borioni, A., Giudice, M. R. D., GATTA, F., Ferretti, R., Meneguz, A., Volpe, M. T., & Lorenzini, P. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01324-1 · Cited by 40
Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice
Li, H., Ip, S., Zheng, G., Xian, Y., & Lin, Z. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0187-8 · Cited by 43
Neurodegeneration: Diagnosis, Prevention, and Therapy
Poddar, M. K., Chakraborty, A., & Banerjee, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94950 · Cited by 51
Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease
Mufson, E. J., Counts, S., Che, S., & Ginsberg, S. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 41
Gonzalo‐Ruiz, A., González, I., & Anquela, J. M. S. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00046-2 · Cited by 42
Barbosa, M., Rios, O., Velásquez, M. A., Villalobos, J., & Ehrmanns, J. (2001) · Surgical Neurology · doi:10.1016/s0090-3019(01)00351-2 · Cited by 40
Dam, D. V., Marescau, B., Engelborghs, S., Cremers, T. I. F. H., Mulder, J., Staufenbiel, M., & Deyn, P. P. D. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2004.11.005 · Cited by 40
Madhavadas, S., & Subramanian, S. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1194593 · Cited by 46
First one in, last one out: the role of GABAergic transmission in generation and degeneration
Davies, P. J., Anderton, B. H., Kirsch, J., Konnerth, A., Nitsch, R., & Sheetz, M. P. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00024-0 · Cited by 42
Cognitive differences between patients with progressive Supranuclear Palsy and Alzheimer's disease
Milberg, W., & Albert, M. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400919 · Cited by 40
Lang, A. E. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046436 · Cited by 40
Cognitive enhancing properties of β-CCM infused into the nucleus basalis magnocellularis of the rat
Mayo, W., Dellu-Hagedorn, F., Cherkaoui, J., Chapouthier, G., Dodd, R. H., Moal, M. L., & Simon, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91168-e · Cited by 41
Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease
Jotkowitz, S. (1983) · Annals of Neurology · doi:10.1002/ana.410140616 · Cited by 40
Neuroprotective therapeutic strategies comparison of experimental and clinical results
Gerlach, M., Riederer, P. F., & Youdim, M. B. H. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00051-z · Cited by 40
Kordower, J. H., Gash, D. M., Bothwell, M. A., Hersh, L. B., & Mufson, E. J. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90068-7 · Cited by 40
Effects of intraseptal injection of 192-IgG-saporin in mature and aged Long-Evans rats
Bannon, A. W., Curzon, P., Gunther, K. L., & Decker, M. W. (1996) · Brain Research · doi:10.1016/0006-8993(95)01568-x · Cited by 40
Soma, S., Suematsu, N., Sato, A., Tsunoda, K., Bramian, A., Reddy, A., Takabatake, K., Karube, F., Fujiyama, F., & Shimegi, S. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107484 · Cited by 39
Counts, S. E., Che, S., Ginsberg, S. D., & Mufson, E. J. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.02.004 · Cited by 35
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease
Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 40
Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology
Mesulam, M.-M., Lalehzari, N., Rahmani, F., Ohm, D., Shahidehpour, R., Kim, G., Gefen, T., Weintraub, S., Bigio, E., & Geula, C. (2019) · Neurology · doi:10.1212/wnl.0000000000007247 · Cited by 39
Li, Y., Li, Y., & Chen, J. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106438 · Cited by 39
Marcelo, F., Dias, C., Martins, A., Madeira, P. J. A., Jorge, T. F., Florêncio, M. H., Cañada, F. J., Cabrita, E. J., Jiménez‐Barbero, J., & Rauter, A. P. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201203966 · Cited by 50
Benke, T., Köylü, B., Delazer, M., Trinka, E., & Kemmler, G. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01063.x · Cited by 39
Acetylcholine in the cerebral cortex: Effects and clinical implications
Benarroch, E. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ee267e · Cited by 42
Pharmacological models in Alzheimer's disease research
Gilles, C., & Ertle, S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/cgilles · Cited by 43
Neufeld, M. Y., Rabey, M. J., Parmet, Y., Sifris, P., Treves, T. A., & Korczyn, A. D. (1994) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(94)90162-7 · Cited by 39
Disease-Specific Brain Atlases
Thompson, P. M., Mega, M. S., & Toga, A. W. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50009-3 · Cited by 42
Martignoni, E., Bono, G., Blandini, F., Sinforiani, E., Merlo, P., & Nappi, G. (1991) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251133 · Cited by 39
MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.
Sasaki, M., Ehara, S., Tamakawa, Y., Takahashi, S., Tohgi, H., Sakai, A., & Mita, T. (1995) · PubMed · Cited by 42
Martínez‐Murillo, R., Semenenko, F. M., & Cuello, A. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90767-6 · Cited by 39
Monoaminergic Innervation of Cingulate Cortex
Crino, P. B., Morrison, J. H., & Hof, P. R. (1993) · Neurobiology of Cingulate Cortex and Limbic Thalamus · doi:10.1007/978-1-4899-6704-6_10 · Cited by 40
Amoah, V., Atawuchugi, P., Yakubu, J., Tandoh, A., Ossei, P. P. S., ., G. H. S., & Ainooson, G. K. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2023.2209130 · Cited by 44
Araujo, J. A., Chan, A. D. F., Winka, L. L., Seymour, P. A., & Milgram, N. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1777-y · Cited by 42
Jiang, X., Wang, Y., Liu, C., Xing, C., Wang, Y., Lyu, W., Wang, S., Li, Q., Chen, T., Chen, Y., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115940 · Cited by 38
Smith, C. P., Bores, G. M., Petko, W. W., Li, M., Selk, D. E., Rush, D. K., Camacho, F., Winslow, J. T., Fishkin, R. J., Cunningham, D., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36441-9 · Cited by 38
Structural determinants of the roles of acetylcholine in cerebral cortex
Descarries, L., Mechawar, N., Aznavour, N., & Watkins, K. C. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45002-4 · Cited by 40
Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines
Zhu, X. ‐., & Giacobini, E. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410613 · Cited by 39
Jolkkonen, J., Soininen, H. S., Halonen, T., Ylinen, A., Laulumaa, V., Laakso, M. P., & Riekkinen, P. J. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.12.1374 · Cited by 38
Basal forebrain amnesia: does the nucleus accumbens contribute to human memory?
Goldenberg, G., Schuri, U., Gromminger, O., & Arnold, U. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.163 · Cited by 38
Baud, P., Mayo, W., Moal, M. L., & Simon, H. (1988) · Brain Research · doi:10.1016/0006-8993(88)90024-8 · Cited by 38
Freeburn, A., & Munn, R. G. K. (2021) · Neuronal Signaling · doi:10.1042/ns20200011 · Cited by 37
Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37
Mufson, E. J., He, B., Ginsberg, S. D., Carper, B. A., Bieler, G. S., Crawford, F., Alvarez, V. E., Huber, B. R., Stein, T. D., McKee, A. C., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5368 · Cited by 40
Allard, S. T. M., Jacobs, M. L., Carmo, S. D., & Cuello, A. C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.002 · Cited by 39
Matsuda, Y., Hirano, H., & Watanabe, Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02465-4 · Cited by 37
Orta‐Salazar, E., Aguilar-Vázquez, A. R., Martínez‐Coria, H., Anda, S. L.-D., Rivera-Cervantes, M. C., Beas‐Zárate, C., Feria‐Velasco, A., & Díaz-Cintra, S. Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.013 · Cited by 41
Guan, Y., Gao, N., Ren, J., & Qu, X. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603233 · Cited by 37
Kwakowsky, A., Milne, M., Waldvogel, H. J., & Faull, R. L. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122122 · Cited by 40
Cholinergic manipulations and passive avoidance in the rat: effects on acquisition and recall
Wilson, W., & Cook, J. (1994) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1994-1044 · Cited by 37
Monoaminergic neurotransmitters in Alzheimer's disease
Herregodts, P., Bruyland, M., Keyser, J. D., Solheid, C., Michotte, Y. M., & Ebinger, G. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90179-2 · Cited by 39
Differential effects of lipid-lowering agents on human cholinesterases
Darvesh, S., Martin, E. V., Walsh, R., & Rockwood, K. J. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.09.004 · Cited by 42
Morawski, M., Hartlage-Rübsamen, M., Jäger, C., Waniek, A., Schilling, S., Schwab, C., McGeer, P. L., Arendt, T., Demuth, H.-U., & Roßner, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0685-y · Cited by 36
Engeland, C. G., Mahoney, C., Mohr, E., Ilivitsky, V., & Knott, V. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00711-6 · Cited by 40
Abdulla, F. A., Abu-Bakra, M. A. J., Calaminici, M., Stephenson, J. D., & Sinden, J. D. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80006-d · Cited by 41
Robert, P. H. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000561 · Cited by 43
Galanthamine treatment in Alzheimer’s disease
Dal‐Bianco, P., Maly, J., Wöber, C., Lind, C., Koch, G., Hufgard, J., Marschall, I., Mraz, M., & Deecke, L. (1991) · Springer eBooks · doi:10.1007/978-3-7091-9135-4_10 · Cited by 37
Wanibuchi, F., Konishi, T., Harada, M., Terai, M., Hidaka, K., TAMURA, T., Tsukamoto, S., & Usuda, S. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90374-f · Cited by 40
Chrobak, J. J., Spates, M. J., Stackman, R. W., & Walsh, T. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)91367-x · Cited by 37
Chen, G., Chen, P., Tan, H., Ma, D., Dou, F., Feng, J., & Yan, Z. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.023 · Cited by 36
Orta‐Salazar, E., Cuellar-Lemus, C. A., Díaz-Cintra, S. Y., & Feria‐Velasco, A. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.10.010 · Cited by 36
The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase
Vignaux, P. A., Minerali, E., Lane, T. R., Foil, D. H., Madrid, P. B., Puhl, A. C., & Ekins, S. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00466 · Cited by 37
Patel, S., Howard, D., Chowdhury, N., Casey, D., Wellslager, B., Yilmaz, Ö., & French, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.646259 · Cited by 39
Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
Manni, L., Conti, G., Chiaretti, A., & Soligo, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754502 · Cited by 36
Neuropharmacology of Verbal Perseveration
McNamara, P., & Albert, M. L. (2004) · Seminars in Speech and Language · doi:10.1055/s-2004-837244 · Cited by 41
Farlow, M. R., & Cyrus, P. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017238 · Cited by 37
Roßner, S. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00035-x · Cited by 38
Kesner, R. P., Crutcher, K. A., & Omana, H. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90376-f · Cited by 36
Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram
Walsh, R., Rockwood, K. J., Martin, E. V., & Darvesh, S. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.010 · Cited by 36
Butler, T., Harvey, P., Deshpande, A., Tanzi, E. B., Li, Y., Tsui, W., Silver, C., Fischer, E., Wang, X., Chen, J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.014 · Cited by 37
Bortolami, M., Pandolfi, F., Tudino, V., Messore, A., Madia, V. N., de Vita, D., di Santo, R., Costi, R., Romeo, I., Alcaro, S., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00485 · Cited by 34
The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy
Carmo, S. D., Kannel, B., & Cuello, A. C. (2021) · Cells · doi:10.3390/cells11010016 · Cited by 37
Hong, S.-W., Yoo, D.-H., Woo, J.-Y., Jeong, J.-J., Yang, J.-H., & Kim, D. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4046528 · Cited by 37
Evidence that mnesic states govern normal and disordered memory
Colpaert, F. C., Koek, W., & Slot, L. A. B. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200112000-00002 · Cited by 36
Effects of scopolamine on anterograde and remote memory in humans
Tröster, A. I., Beatty, W. W., Staton, R. D., & Rorabaugh, A. G. (1989) · Psychobiology · doi:10.3758/bf03337812 · Cited by 36
Apolipoprotein E and Alzheimer's disease: a genetic, molecular and neuroimaging review.
Swartz, R. H., Black, S. E., & George‐Hyslop, P. S. (1999) · PubMed · Cited by 46
Masliah, E., Terry, R. D., & Buzsáki, G. (1989) · Brain Research · doi:10.1016/0006-8993(89)91159-1 · Cited by 35
Altar, C. A., & Bakhit, C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91077-e · Cited by 39
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.